A61K38/16

SRPX for treatment of cancer

Methods of treating a tumor in a subject include identifying a subject having, at risk for, or suspected of having a tumor, and administering to the subject an effective amount of an SRPX.

METHODS FOR TREATMENT OF MASSETER MUSCLE HYPERTROPHY
20230083250 · 2023-03-16 ·

Methods and kits for treating or alleviating masseter muscle hypertrophy by local administration of a Clostridial derivative, such as a botulinum toxin, to the masseter muscle are described. Methods and kits for reducing lower face width and for reducing prominence of the masseter muscle of a human are also described.

ATP-binding cassette family coding polyribonucleotides and formulations thereof

Polynucleotides encoding peptides, proteins, enzymes, and functional fragments thereof are disclosed. The polynucleotides of the disclosure can be effectively delivered to an organ, such as the lung, and expressed within cells of the organ. The polyribonucleotides of the disclosure can be used to treat a disease or condition associated with a gene of the ATP-binding cassette (ABC) family, such as ABCA3.

ATP-binding cassette family coding polyribonucleotides and formulations thereof

Polynucleotides encoding peptides, proteins, enzymes, and functional fragments thereof are disclosed. The polynucleotides of the disclosure can be effectively delivered to an organ, such as the lung, and expressed within cells of the organ. The polyribonucleotides of the disclosure can be used to treat a disease or condition associated with a gene of the ATP-binding cassette (ABC) family, such as ABCA3.

FHSS hotspot device and methods
11478545 · 2022-10-25 · ·

A wireless wideband transceiver may be able to communicate with multiple frequency-hopped spread-spectrum (FHSS) devices concurrently over multiple frequencies over a short range by including a plurality of digital chains corresponding to the FHSS physical channels, individually and dynamically compensated for in-phase/quadrature imbalance in the transmit and/or receive portion. To further improve communications the transceiver may also mitigate cross interference between adjacent channel signals that are received and/or transmitted simultaneously, avoid false reception and/or transmission of co-channel signals, delay respective FHSS channels transmissions relative to other channels transmissions, speed up connection to FHSS devices and coordinate Time Division Duplexing (TDD) operation according to application dependent TX/RX binary pattern. A device that includes such a transceiver (FHSS-hotspot) may enable the concurrent usage of multiple commercially available FHSS peripheral devices without the need for additional personal host devices to be carried along with them, and in addition enable the concurrent usage of multiple commercially available FHSS personal data devices while reducing their radiation and/or latency and/or usage cost and/or power, to establish a localized multi-device multimedia session, and/or to interface with a communications network to communicate with remote parties, and/or to interface with broadcast devices to stream contents.

Absorbent structure for absorbent articles

Absorbent structures for absorbent articles are provided. The absorbent structure includes an absorbent layer with absorbent material supported by a supporting sheet, and a channel that is free of said absorbent material. The channel has a wet integrity of at least 20%.

Absorbent structure for absorbent articles

Absorbent structures for absorbent articles are provided. The absorbent structure includes an absorbent layer with absorbent material supported by a supporting sheet, and a channel that is free of said absorbent material. The channel has a wet integrity of at least 20%.

Method for stabilization and delivery of therapeutic molecules
11602564 · 2023-03-14 · ·

A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.

Method for stabilization and delivery of therapeutic molecules
11602564 · 2023-03-14 · ·

A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.

Method for stabilization and delivery of therapeutic molecules
11602564 · 2023-03-14 · ·

A method of treatment is disclosed, comprising administering a composition of Cyclodextrin and reduced, nanonized L-Glutathione to a patient in need of treatment, wherein the L-Glutathione molecule is non-acetylated, non-Esterified, and non-fatty acid attached.